Two novel approaches for the development of new drugs against AIDS are summarized each leading to the achievement of important discoveries in anti-HIV therapy. Despite the success of HAART in reducing mortality, resistant strains continue to emerge in the clinic, underscoring the importance of developing next-generation drugs. Protein protein interactions and human cellular cofactors represent the new targets of tomorrow in HIV research. The most relevant results obtained in the last few years by the two new strategies are described herein.
Tintori, C., Brai, A., Fallacara, A.L., Fazi, R., Schenone, S., Botta, M. (2014). Protein-protein interactions and human cellular cofactors as new targets for HIV therapy. CURRENT OPINION IN PHARMACOLOGY, 18, 1-8 [10.1016/j.coph.2014.06.005].
Protein-protein interactions and human cellular cofactors as new targets for HIV therapy
TINTORI, CRISTINA;BRAI, ANNALAURA;FALLACARA, ANNA LUCIA;FAZI, ROBERTA;BOTTA, MAURIZIO
2014-01-01
Abstract
Two novel approaches for the development of new drugs against AIDS are summarized each leading to the achievement of important discoveries in anti-HIV therapy. Despite the success of HAART in reducing mortality, resistant strains continue to emerge in the clinic, underscoring the importance of developing next-generation drugs. Protein protein interactions and human cellular cofactors represent the new targets of tomorrow in HIV research. The most relevant results obtained in the last few years by the two new strategies are described herein.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/982065
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo